Zusammenfassung
Wie der Begriff schon sagt, ist bei diesem Krankheitsbild nicht ein einzelnes Organ betroffen. Vielmehr handelt es sich um multiple Störungen, die nicht nur den Bewegungsapparat betreffen. Gemeinsam ist diesen Erkrankungen, dass sie mit nur wenigen Ausnahmen erblich sind und somit als Heredopathien bezeichnet werden und dass sie in aller Regel mit einem Klein- oder Zwergwuchs einhergehen (Endgröße von <150 cm). Obwohl diese Erkrankungen sehr heterogene Auswirkungen haben, ist es insbesondere der Kleinwuchs, der in der Gesellschaft des 21. Jahrhunderts mit ihren hohen ästhetischen Anforderungen im Vordergrund steht.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agarwal V, Joseph B (2005) Non-union in osteogenesis imperfecta. J Pediatr Orthop B 14: 451–455
Aldenhoven M, Sakkers RJ, Boelens J (2009) Musculoskeletal manifestations of lysosomal storage disorders. Ann Rheum Dis 68: 1659–1665
Ankrom MA, Shapiro JR (1998) Paget’s disease of bone (osteitis deformans). J Am Geriatr Soc 46: 1025–1033
Aroldi A, Tarantino A, Montagnino G, Cesana B, Cocucci C, Ponticelli C (1997) Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study. Transplantation 63: 380–386
Bailey K (1963) Studies of longitudinal bone grosth resulting in an extensible nail. Surg Forum 14: 455
Baumert U, Golan I, Redlich M, Aknin JJ, Muessig D (2005) Cleidocranial dysplasia: molecular genetic analysis and phenotypic-based description of a Middle European patient group. Am J Med Gen 139A (2): 78–85
Beck M (2007) Lysosomale Speicherkrankheiten. Monatsschr Kinderheilkd 155: 653–662
Beckmann J, Köck F, Tingart M, Goetz J, Grifka J, Schaumburger J (2008) Pseudarthrosis in fibrous dysplasia treated with BMP. CEJMed 3: 377–379
Black D et al. (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356: 1809–1822
Black DM, Greenspan SL, Ensrud KE et al. (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349: 1207–1215
Bone HG, Kleerekoper M (1992) Clinical review 39: Paget’s disease of bone. J Clin Endocrinol Metab 75: 1179–1182
Bourke E, Delaney V (1993) Assessment of hypocalcemia and hypercalcemia. Clin Lab Med 13: 157–181
Boutaud B, Laville J M (2004) L’embrochage centro-medullaire coulissant dans l’osteogenese imparfaite. Quatorze cas avec un recul moyen de 8 ans. Rev Chir Orthop Reparatrice Appar Mot 90: 304–311
Bovée JV (2008) Multiple osteochondromas. Orphanet J Rare Dis 3: 3
Cho T J, Choi IH, Chung CY, Yoo WJ, Lee KS, Lee DY (2007) Interlocking telescopic rod for patients with osteogenesis imperfecta. J Bone Joint Surg Am 89: 1028–1035
Daly K, Wisbeach A, Sanpera I, Fixsen JA (1996) The prognosis for walking in osteogenesis imperfecta. J Bone Joint Surg Br 78: 477–480
DiCaprio MR, Enneking WF (2005) Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 87: 1848–1864
Drake WM, Kendler DL, Brown JB (2001) Consensus statement on the modern therapy of Paget’s disease of bone from a western osteoporosis alliance symposium. Clin Ther 23: 620–626
Enderle A (2003) Osteochondrodysplasien. In: Zichner L (Hrsg.) Systemerkrankungen. Stuttgart: Thieme, S. 34–36
Engelbert RH, Uiterwaal CS, Gerver WJ, Van Der Net JJ, Pruijs HE, Helders PJ (2004) Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up. Arch Phys Med Rehabil 85: 772–778
Engelbert RH, Uiterwaal CS, Gulmans VA, Pruijs HE, Helders PJ (2000) Osteogenesis imperfecta: profiles of motor development as assessed by a postal questionnaire. Eur J Pediatr 159: 615–620
Ettinger B, Black DM, Mitlak BH et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 282: 637–645
Garnero P, Hausherr E, Chapuy MC et al. (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 11: 1531–1538
Gerber LH, Binder H, Weintrob J et al. (1990) Rehabilitation of children and infants with osteogenesis imperfecta. A program for ambulation. Clin Orthop Relat Res 251: 254–262
Golan I, Baumert U, Hrala BP et al. (2003) Symptome und Merkmale bei Dysostosis Cleidocranialis. Z Orthop 141: 336–340
Gray JR, Davies SJ (1996) Marfan syndrome. J Med Genet 33: 403–408
Grennberg B, Winters RW, Graham JB (1960) The normal range of serum inorganic phosphorus and its utility as a discriminant in the diagnosis of congenital hypophosphatemia. J Clin Endocr Metab 20: 364–379
Harrison WJ, Rankin KC (1998) Osteogenesis imperfecta in Zimbabwe: a comparison between treatment with intramedullary rods of fixed-length and self-expanding rods. J R Coll Surg Edinb 43: 328–332
Hefti F (2006a) Skelettdysplasien. In: Hefti F (Hrsg.) KinderOrthopädie in der Praxis. Springer, Berlin Heidelberg New York Tokyo, S. 649–684
Hefti F (2006b) Neurofibromatose. In: Hefti F (Hrsg.) KinderOrthopädie in der Praxis. Springer, Berlin Heidelberg New York Tokyo, S. 697–699
Hellemans J et al. (2004) Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet 36: 1213–1218
Herring JA (2008) Tachdjian’s pediatric orthopaedics. Saunders Elsevier, Philadelphia
Horton WA, Hall JG, Hecht JT (2007) Achondroplasia. Lancet 370: 162–172
Hosking D et al. (1996) Paget’s disease of bone: diagnosis and management. BMJ 312: 491–494
Joseph B, Rebello G, BCK (2005) The choice of intramedullary devices for the femur and the tibia in osteogenesis imperfecta. J Pediatr Orthop B 14: 311–319
Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325: 544–550
Jundt G, Baumhoer D (2008) Chondrogene Tumoren des Skeletts. Pathologe 29: 223–231
Karbowski A, Schwitalle M, Eckardt A (1998) Erfahrungen mit unterschiedlichen Teleskopnägeln zur Behandlung kindlicher Osteogenesis imperfecta-Patienten. Zentralbl Chir 123: 1252–1256
Kehrer-Sawatzki H, Mautner VF (2009) Klinik und Genetik der Neurofibromatose Typ I. Med Gen 21: 519–531
Kohler G (2005) Tumorartige Läsionen und benigne Knochentumoren. In: Winkelmann W (Hrsg.) Tumoren, tumorahnliche Erkrankungen. Stuttgart: Thieme, S. 79
Kornak U (2004) Genetik und Pathophysiologie der Osteopetrose. Med Gen 16: 39–43
Link B, Miebach E, Vetter T, Schmitt D, Beck M, Meurer A (2008) Mukopolysaccharidosen. Orthopädie 37: 24–30
Luhmann SJ, Sheridan JJ, Capelli AM, Schoenecker PL (1998) Management of lower-extremity deformities in osteogenesis imperfecta with extensible intramedullary rod technique: a 20-year experience. J Pediatr Orthop 18: 88–94
Marshall D, Johnell O, Wedel H (1996) Metaanalysis of how well measures of bone mineral density predict occurence of osteoporotic fractures. BMJ 12: 1254–1259
McClatchey AI (2007) Neurofibromatosis. Annu Rev Pathol Mech Dis 2: 191–216
McClung MR, Geusens P, Miller PD et al. (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344: 333–340
Meunier PJ, Roux C, Seeman E et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in woman with postmenopausal osteoporosis. N Engl J Med 350: 459–468
Mulpuri K, Joseph B (2000) Intramedullary rodding in osteogenesis imperfecta. J Pediatr Orthop 20: 267–273
Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH (2004) Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 19: 1779–1786
Neer RM et al. (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 1434–1441
NIH (1988) Neurofibromatosis. National Health Consensus Development Conference Statement, Bethesda, MD, USA, July 13–15, 1987. Neurofibromatosis 1: 172–178
Parekh SG, Donthineni-Rao R, Ricchetti E, Lackman RD (2004) Fibrous dysplasia. J Am Acad Orthop Surg 12: 305–313
Paterson CR, Naismith KI, Young JA (1992) Severe unexplained hypophosphatemia. Clin Chem 38: 104–107
Payne RB, Carver ME, Morgan DB (1979) Interpretation of total calcium: effects of adjustment for albumin concentration of frequency of abnormal values and on detection of change in the individual. J Clin Pathol 32: 56–60
Pizones J, Plotkin H, Parra-Garcia JI et al. (2005) Bone healing in children with osteogenesis imperfecta treated with bisphosphonates. J Pediatr Orthop 25: 332–335
Pollandt K, Engels S, Werner M, Delling G (2002) Fibröse Dysplasie. Pathologe 23: 351–356
Pons F, Martinez de Osaba MJ (1995) Evolution of bone mineral density after renal transplantation: related factors. Nephrol Dial Transplant 10 (Suppl 6): 111–113
Reid IR, Miller P, Lyles K et al. (2005) A single infusion of zoledronic acid improves remission rates in Paget’s disease: a randomized controlled comparision with risedronate. N Engl J Med 353: 898–908
Ring D, Jupiter JB, Labropoulos PK, Guggenheim JJ, Stanitsky DF, Spencer DM (1996) Treatment of deformity of the lower limb in adults who have osteogenesis imperfecta. J Bone Joint Surg Am 78: 220–225
Rödl R, Götze C (2008) Fibröse Dysplasie. Orthopädie 37: 49–55
Rogers MJ, Gordon S, Benford HL et al. (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88: 2961–2978
Rossouw JE, Anderson GL, Prentice RL et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288: 321–333
Saldanha KA, Saleh M, Bell MJ, Fernandes JA (2004) Limb lengthening and correction of deformity in the lower limbs of children with osteogenesis imperfecta. J Bone Joint Surg Br 86: 259–265
Sanchez CP, Goodman WG, Salusky IB (1999) Prevention of renal osteodystrophy in predialysis patients. Am J Med Sci 317: 398–404
Seebach C, Kurth A, Marzi I (2007) Einfluss der Bisphosphonate auf die Frakturheilung. Orthopädie 36: 136–140
Selby PL, Davie MW, Ralston SH, Stone MD, Bone and Tooth Society Great Britain, National Association for the Relief of Paget’s Disease (2002) Guidelines on the management of Paget’s disease of bone. Bone 31: 366–373
Siris ES (1999) Goals of treatment for Paget’s disease of bone. J Bone Miner Res 14 (Suppl 2): 49–52
Sliman N (1981) Osteogenesis imperfecta: An expanding panorama of variants. Clin Orthop Relat Res 159: 11–25
Spranger J (1992) International classification of osteochondrodysplasias, international working-group on constitutional disease of bone. Eur J Pediat 151: 407–415
Stott NS, Zionts LE (1993) Displaced fractures of the apophysis of the olecranon in children who have osteogenesis imperfecta. J Bone Joint Surg Am 75: 1026–1033
Tolar (2004) Osteopetrosis. N Engl J Med 351: 2839–2849
Uebelhart D, Gineyts E, Chapuy MC, Delmas PD (1990) Urinary excretion of pyridinium links; a new marker of bone resorption in metabolic bone disease. Bone Miner 8: 87–96
Weber U, Robinson Y, Kayser R (2006) Seltene krankhafte Veranderungen der oberen Halswirbelsäule mit operativer Behandlungsindikation. Orthopädie 35: 296–305
Woitge HW, Seibel MJ, Ziegler R (1996) Comparison of total and bonespecific alkaline phosphatase in patients with nonskeletal disorders or metabolic bone diseases. Clin Chem 42: 1796–1804
Wong GL (1979) Basal activities and hormone responsiveness of osteoblastic activity. J Biol Chem 254: 6337–6340
Zichner (2003a) Osteochondrodysplasien. In: Zichner L (Hrsg.) Systemerkrankungen. Stuttgart: Thieme, S. 45–47
Zichner L (2003b) Osteopetrose. In: Zichner L (Hrsg.) Systemerkrankungen. Stuttgart: Thieme, S. 129–132
Zichner L (2003c) Osteopoikilie. In: Zichner L (Hrsg.) Systemerkrankungen. Stuttgart: Thieme, S. 136–137
Zichner L (2007) Angebohrene Skelettsystemerkrankungen. In: Wirth CJ, Mutschler W (Hrsg.) Praxis der Orthopädie und Unfallschirurgie. Stuttgart: Thieme, S. 111
Zichner L, Enderle A (2003) Down-Syndrom. In: Zichner L (Hrsg.) Systemerkrankungen. Stuttgart: Thieme, S. 99–102
Zichner L, Enderle A (2003a) Mukopolysaccharidosen. In: Zichner L (Hrsg.) Systemerkrankungen. Stuttgart: Thieme, S. 75–83
Zichner L, Enderle A (2003b) Oligosaccharidosen. In: Zichner L (Hrsg.) Systemerkrankungen. Stuttgart: Thieme, S. 83–84
Zichner L, Enderle A (2003c) Osteochondrodysplasien. In: Zichner L (Hrsg.) Systemerkrankungen. Stuttgart: Thieme, S. 17–28
Zionts LE, Ebramzadeh E, Stott NS (1998) Complications in the use of the Bailey-Dubow extensible nail. Clin Orthop Relat Res 348: 186–195
Internetadressen
Deutsche OI-Gesellschaft: www.oi-gesellschaft.de
Internationale OI-Gesellschaft: www.oif.org
OI-Klinik, Baltimore, USA: www.osteogenesisimperfecta.org
Schweizerische OI-Gesellschaft: www.svoi-asoi.ch
Dachverband Osteologie (DVO): www.dv-osteologie.org
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Grifka, J., Kuster, M. (2011). Skelettsystemerkrankungen. In: Grifka, J., Kuster, M. (eds) Orthopädie und Unfallchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13111-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-13111-0_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-13110-3
Online ISBN: 978-3-642-13111-0
eBook Packages: Medicine (German Language)